Type 2 diabetes

Dr Ted Wu: the impact of hypoglycaemia on insulin optimisation in type 2 diabetes

Sponsored by Sanofi-aventis Australia Pty Ltd

Hypoglycaemia is an ongoing concern in patients with type 2 diabetes treated with insulin and can have serious acute and long-term impacts.1 To better understand the impact of hypoglycaemia on insulin optimisation, the limbic spoke with Dr Ted Wu, Director of the Diabetes Centre, Royal Prince Alfred Hospital in Sydney. “A lot of hypoglycaemia in ...

Already a member?

Login to keep reading.

© 2021 the limbic